98792-02-0

Basic information

• Product Name: 1-CHLORO-9H-2,4,9-TRIAZA-FLUORENE
• Synonyms: 1-CHLORO-9H-2,4,9-TRIAZA-FLUORENE;5H-Pyrimido[5,4-b]indole, 4-chloro-;4-chloro-5H-pyrimido[5,6-b]indole
• CAS NO: 98792-02-0
• Molecular Formula: C₁₀H₆ClN₃
• Molecular Weight: 203.63
• Mol File: 98792-02-0.mol

Chemical Properties

• Boiling Point: 416.8°C at 760 mmHg
• Flash Point: 238.4°C
• Appearance: /
• Density: 1.515g/cm³
• Vapor Pressure: 8.98E-07mmHg at 25°C
• Refractive Index: 1.8
• CAS DataBase Reference: 1-CHLORO-9H-2,4,9-TRIAZA-FLUORENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-CHLORO-9H-2,4,9-TRIAZA-FLUORENE(98792-02-0)
• EPA Substance Registry System: 1-CHLORO-9H-2,4,9-TRIAZA-FLUORENE(98792-02-0)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 98792-02-0(Hazardous Substances Data)

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 11 carbon atoms, 7 hydrogen atoms, 1 chlorine atom, and 4 nitrogen atoms.

Explanation

1-CHLORO-9H-2,4,9-TRIAZA-FLUORENE is derived from 9H-2,4,9-triaza-fluorene by substituting one hydrogen atom with a chlorine atom.

Explanation

Due to its unique structure and properties, the compound is used as an intermediate in the synthesis of various organic compounds. It also has potential applications in the development of new drugs and is utilized in pharmaceutical research.

Explanation

The compound's unique structure and properties make it a valuable intermediate in the field of chemical synthesis, allowing for the creation of a wide range of organic compounds and potential drug candidates.

Chemical Structure

Heterocyclic aromatic compound with a triazabenzene ring system

Chloro-substituted derivative

9H-2,4,9-triaza-fluorene

Applications

Organic synthesis, pharmaceutical research, drug development, and production of various organic compounds

Importance

Important intermediate in chemical synthesis

InChI:InChI=1/C10H6ClN3/c11-10-9-8(12-5-13-10)6-3-1-2-4-7(6)14-9/h1-5,14H

Upstream product

• 61553-71-7 5H-pyrimido<5,4-b>indole-4-one 
• 87223-77-6 ethyl 3-amino-1H-indole-2-carboxylate 
• 97311-03-0 3-(dimethylamino-methyleneamino)-1H-indole-2-carboxylic acid ethyl ester 
• 1885-29-6 anthranilic acid nitrile 
• 25116-00-1 2-acetamidobenzonitrile 

Downstream Products

• 107401-00-3 4-(1-piperidinyl)-5H-pyrimido<5,4-b>indole 
• 132994-29-7 4-p-Tolyloxy-5H-pyrimido[5,4-b]indole 
• 132994-27-5 4-ethoxypyrimido<5,4-b>indole 
• 107401-01-4 4-hydrazino-5H-pyrimido<5,4-b>indole 
• 132994-28-6 4-(4-Chloro-phenoxy)-5H-pyrimido[5,4-b]indole 
• 132994-34-4 (1-Methyl-2-phenyl-ethyl)-(5H-pyrimido[5,4-b]indol-4-yl)-amine 
• 132994-30-0 4-(4-Methoxy-phenoxy)-5H-pyrimido[5,4-b]indole 
• 132994-32-2 N-phenyl-5H-pyrimido[5,4-b]indole-4-amine 
• 132994-33-3 4-benzylaminoindolo[3,2-d]pyrimidine 
• 676601-64-2 1-{4-[2-(3,4-difluorophenyl)ethyl]piperazin-1-yl}-9H-2,4,9-triazafluoren-6-ylamine 
• 676601-59-5 1-{4-[2-(3,4-difluoro-phenyl)ethyl]-piperazin-1-yl}-6-nitro-9H-2,4,9-triaza-fluorene 
• 132994-36-6 4-Benzylsulfanyl-5H-pyrimido[5,4-b]indole 
• 320420-18-6 (4-phenylpiperazin-1-yl)-5H-pyrimido[5,4-b]indole 

Relevant articles and documents

9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein

P-Glycoprotein (P-gp, ABCB1), multidrug resistance-associated protein 1 (MRP1, ABCC1), and breast cancer resistance protein (BCRP, ABCG2) are the three major ABC transport proteins conferring resistance to many structurally diverse anticancer agents, lead

The pyrimidine or pyridine-containing condensed ring compounds and their use as anti-tumor medicament (by machine translation)

Disclosed in the invention are a fused ring compound containing pyrimidine or pyridine and the use thereof as an anti-tumour drug. teT fused ring compound is a compound as shown by formula (I) or a pharmaceutical acceptable salt thereof; the compound of t

Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases

Described herein are compounds and compositions for modulating kinase activity, and methods for modulating kinase activity using the compounds and compositions. Also described herein are methods of using the compounds and/or compositions in the treatment

PYRROLOPYRIMIDINE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE (MDR)

A compound which is a pyrrolopyrimidine of formula (I) wherein R1 is selected from H, Cl-C6 alkyl which is unsubstituted or substituted, (CH2)nAr1, (CH2)pNR4R5, halogen and (CH2)pX; R2 is CH2)pArl; R3 is selected from H, Cl -C6 alkyl which is unsubstituted or substituted, (CH2)pZ and (CH2)pArl; P is an unsaturated 5, 6, or 7 membered carbocyclic or heterocyclic ring which is unsubstituted or substituted; R4 and R5 which are the same or different are selected from H, Cl -C6 alkyl which is unsubstituted or substituted, (CH2)nC3-C10 cycloalkyl, (CH2)nAr1 , and (CH2)nOR6, or R4 and R5 together with the nitrogen atom to which they are attached, form a saturated five or six membered nitrogen containing heterocyclic ring which may contain one extra heteroatom selected from 0, N and S and which is unsubstituted or substituted; R6 is selected from H, Cl -C6 alkyl which is unsubstituted or substituted, C3-C10 cycloalkyl, (CH2)nOC1-C6alkyl which is unsubstituted or substituted, (CH2)nO(CH2)nAr1 , (CH2)nCO2C1-C6,alkyl which is unsubstituted or substituted and (CH2)nAr1; X is selected from CN, azide, (CH2)nNHSO2R6 and (CH2)nNHCOR6; Z is selected from CN, CO2R6 and CONR4R5; Ar1 is the same or different when more than one is present within a given substituent group and is an unsaturated C6-C10 membered carbocylic group or an unsaturated 5-11 membered heterocycle, either of which is unsubstituted or substituted; p is an integer of 1 to 6; n is the same or different when more than one is present within a given substituent group and is 0 or an integer of 1 to 6; with the proviso that the pyrrolepyrimidine compound of formula (I) is other than 1-(4-benzyl-piperazin-1-yl)-9H-2,4,9-triaza-fluorene; and the pharmaceutically acceptable salts thereof, have activity as inhibitors of MRP (multidrug resistant protein) and may thus be used to modulate multidrug resistance, for instance in potentiating the cytotoxicity of a chemotherapeutic agent.

SYNTHESIS AND SOME PROPERTIES OF 4-OXO-3,4-DIHYDRO- AND 2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDOINDOLES

The condensation of N-(2-ethoxycarbonylindol-3-yl)-N',N'-dialkylamidines with ammonia, primary amines, and hydrazines has given a series of 4-oxopyrimidoindoles which have been converted into the 4-chloro and then into the 4-methoxy, 4-dialkylamino